SEC Form 4 · accession 0001209191-18-038335
Adverum Biotechnologies, Inc. · ADVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer C. Cheng
Officer — General Counsel
Period of report
Jun 15, 2018
Accepted (ET)
Jun 18, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 15, 2018 | A | 11,150 | $0.00 | A | 118,863 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) RSU upon the vesting thereof. Such RSUs vest with respect to 100% of the shares on June 15, 2019, subject to the Reporting Person's continued service with the Issuer on the applicable vesting date.